You are viewing a preview of...

Digital and Point-of-Care Microfluidic Electrochemical Biosensor for Rapid, Longitudinal, Rapid, and Low-cost Detection of SARS-CoV-2 Viral Loads and Immunity Levels

Ultrasensitive biosensors, electrical readout systems and an App/Cloud system for digital and quantitative measurement of viral loads


Early diagnosis of COVID-19 infection requires the ability to longitudinally detect SARS-CoV-2 RNAs or viral loads using low-cost and non-invasive diagnostic kits. Also monitoring of immunity levels post-vaccination or post-infection needs quantitative, ultrasensitive, and longitudinal monitoring of host immune antibodies. Technically, none of the commercially available PCR or antigen nasopharyngeal (NP) point-of-care tests have been utilized for longitudinal monitoring of SARS-CoV-2 markers and host antibody response as they are lengthy, invasive, costly, not digital, and still require skilled personnel to operate.

Log in or create a free account to continue reading